These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 15817338

  • 1. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
    Tedesco KL, Berlin J, Blanke CD, Teng M, Choy H, Roberts J, Beauchamp RD, Leach S, Wyman K, Tarpley J, Shyr Y, Caillouette C, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1364-70. PubMed ID: 15817338
    [Abstract] [Full Text] [Related]

  • 2. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG, Cohen DP, Kelsey CR, Lockhart AC, Bendell JC, Willett CG, Petros WP, D'Amico TA, Truax R, Hurwitz HI.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1066-72. PubMed ID: 17881149
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):397-404. PubMed ID: 17097833
    [Abstract] [Full Text] [Related]

  • 4. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 5. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.
    Acta Oncol; 2008 Jun 15; 47(3):428-33. PubMed ID: 18348002
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R, Lassere Y, Diaz-Canton E, Ho DH.
    Cancer Invest; 1998 Jun 15; 16(3):145-51. PubMed ID: 9541627
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 15; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 8. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
    Byström P, Frödin JE, Berglund A, Wilking N, Glimelius B.
    Radiother Oncol; 2004 Feb 15; 70(2):171-5. PubMed ID: 15028404
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J, Cervantes A, Conill C, Salazar R, Martin-Richard M, Pera M, Manzano H, Chirivella I, Gallego R, Marfa X.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):91-6. PubMed ID: 15850907
    [Abstract] [Full Text] [Related]

  • 11. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A, García-Berrocal MI, Arias F, Mariño A, Valcárcel F, Magallón R, Regueiro CA, Romero J, Zapata I, de la Fuente C, Fernández-Lizarbe E, Vergara G, Belinchón B, Veiras M, Molerón R, Millán I.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):102-10. PubMed ID: 17869446
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.
    J Clin Oncol; 2004 Sep 01; 22(17):3466-74. PubMed ID: 15277535
    [Abstract] [Full Text] [Related]

  • 14. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW, Jensen HA, Pfeiffer P.
    Acta Oncol; 2012 Mar 01; 51(3):311-7. PubMed ID: 22248062
    [Abstract] [Full Text] [Related]

  • 15. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P.
    Acta Oncol; 2005 Mar 01; 44(3):224-9. PubMed ID: 16076693
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
    Bhandari MS, Pienta KJ, Fardig J, Olson K, Smith DC.
    Cancer; 2006 Apr 15; 106(8):1715-21. PubMed ID: 16534795
    [Abstract] [Full Text] [Related]

  • 17. Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
    Giralt J, Tabernero J, Navalpotro B, Capdevila J, Espin E, Casado E, Mañes A, Landolfi S, Sanchez-Garcia JL, de Torres I, Armengol M.
    Radiother Oncol; 2008 Dec 15; 89(3):263-9. PubMed ID: 18768230
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
    Kundel Y, Brenner B, Symon Z, Oberman B, Sadezki S, Koller M, Catane R, Pfeffer R.
    Anticancer Res; 2007 Dec 15; 27(4C):2877-80. PubMed ID: 17695464
    [Abstract] [Full Text] [Related]

  • 19. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM, Abacioglu U, Dane F, Ozgen Z, Yumuk PF, Ozden S, Akgun Z, Mayadagli A, Basaran G, Turhal S, Sengoz M.
    J BUON; 2007 Dec 15; 12(2):203-8. PubMed ID: 17600873
    [Abstract] [Full Text] [Related]

  • 20. [Phase I study of orally administered UFT plus l-leucovorin].
    Horikoshi N, Aiba K, Kanamaru R, Hasegawa K, Takeda S, Taguchi T, Niitani H, Furue H, Kurihara M, Ogawa M, Abe T.
    Gan To Kagaku Ryoho; 1998 Mar 15; 25(4):531-9. PubMed ID: 9530359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.